Literature DB >> 9890676

Knee and/or hip joint destruction in rheumatoid arthritis is associated with HLA-DRB1*0405 in Japanese patients.

S Wakitani1, K Kuwata, K Imoto, N Murata, H Oonishi, T Ochi.   

Abstract

To determine the prognostic factors for knee and/or hip joint destruction in rheumatoid arthritis (RA) patients, we typed 379 RA patients for HLA-DRB alleles and analysed the antigen frequencies. The DRB1*0405 antigen frequency in RA patients who underwent total knee replacement and/or total hip replacement was significantly higher than in those who did not have replacements, which meant that DRB1*0405 was associated with knee and/or hip joint destruction. This finding may be of value for predicting knee and/or hip joint destruction in RA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9890676     DOI: 10.1007/bf01451284

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

1.  A SEVEN-DAY VARIABILITY STUDY OF 499 PATIENTS WITH PERIPHERAL RHEUMATOID ARTHRITIS.

Authors:  J R DEANDRADE; P A CASAGRANDE
Journal:  Arthritis Rheum       Date:  1965-04

2.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

3.  Natural course of joint destruction and fluctuation of serum C1q levels in patients with rheumatoid arthritis.

Authors:  T Ochi; R Iwase; K Yonemasu; M Matsukawa; M Yoneda; M Yukioka; K Ono
Journal:  Arthritis Rheum       Date:  1988-01

4.  Four common HLA haplotypes and their association with diseases in the Japanese population.

Authors:  T Sasazuki; H Kaneoka; N Ohta; R Hayase; I Iwamoto
Journal:  Transplant Proc       Date:  1979-12       Impact factor: 1.066

5.  Association between HLA and Japanese patients with rheumatoid arthritis.

Authors:  N Ohta; Y K Nishimura; K Tanimoto; Y Horiuchi; C Abe; Y Shiokawa; T Abe; M Katagiri; T Yoshiki; T Sasazuki
Journal:  Hum Immunol       Date:  1982-10       Impact factor: 2.850

6.  The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese.

Authors:  S Wakitani; N Murata; Y Toda; R Ogawa; T Kaneshige; Y Nishimura; T Ochi
Journal:  Br J Rheumatol       Date:  1997-06

7.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

8.  Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis.

Authors:  H Visser; L B Gelinck; A H Kampfraath; F C Breedveld; J M Hazes
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

9.  Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort.

Authors:  E Fex; K Jonsson; U Johnson; K Eberhardt
Journal:  Br J Rheumatol       Date:  1996-11

10.  Rheumatoid-susceptible alleles of HLA-DRB1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA.

Authors:  Y Toda; Y Minamikawa; S Akagi; H Sugano; Y Mori; H Nishimura; S Arita; Y Sugino; R Ogawa
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

View more
  2 in total

1.  HLA-DRB1 association in Saudi rheumatoid arthritis patients.

Authors:  Ramiz Al-Swailem; Hannan Al-Rayes; Samia Sobki; Misbahul Arfin; Mohammad Tariq
Journal:  Rheumatol Int       Date:  2006-05-04       Impact factor: 2.631

2.  Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction.

Authors:  Kosuke Ebina; Atsunori Fukuhara; Wataru Ando; Makoto Hirao; Tadashi Koga; Kazuya Oshima; Morihiro Matsuda; Kazuhisa Maeda; Tadashi Nakamura; Takahiro Ochi; Iichiro Shimomura; Hideki Yoshikawa; Jun Hashimoto
Journal:  Clin Rheumatol       Date:  2008-12-16       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.